Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine Effect on Microcirculatory Resistance in Stable CAD (PATMOS)
NCT02107144Phase 4Completed
- Sponsor
- Clinical Hospital Center Zemun
- Start
- Apr 2014
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trimetazidine in coronary artery disease (CAD), sponsored by Clinical Hospital Center Zemun. Started Apr 2014; status: completed.
02
Drugs
trimetazidine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02107144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02107144.